Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Subtrochanteric femoral stress fracture with features of atypical femoral fracture in patient with Paget's disease: a case report.

Literature DB >> 29354170

Subtrochanteric femoral stress fracture with features of atypical femoral fracture in patient with Paget's disease: a case report.

Young-Kyun Lee¹, Hong Seok Kim², Hwan Seong Cho¹, Kyung-Hoi Koo¹.

Abstract

Atypical femoral fracture (AFF) has been widely issued since the American Society for Bone and Mineral Research (ASBMR) taskforce stated a possible association with long-term use of bisphosphonate in 2010. ASBMR taskforce recommended to include Paget's disease as one of variables to investigate the AFF in 2010. On the other hand, the ASBMR taskforce in 2014 excluded Paget's disease in the definition of AFF. Still, any rationale has been barely documented about this change. We described the rationale by reporting an 85-year-old man who had a subtrochanteric fracture with features of atypical femoral fracture which turned out to be Paget's disease of bone in the pathology.

Entities: Chemical Disease Species

Keywords: Paget’s disease; atypical femoral fracture

Year: 2017 PMID： 29354170 PMCID： PMC5762232 DOI： 10.11138/ccmbm/2017.14.3.368

Source DB: PubMed Journal: Clin Cases Miner Bone Metab ISSN： 1724-8914

Keyword Cloud
References

26 in total

Review 1. Atypical femoral fractures: epidemiology, etiology, and patient management.

Authors: Eve Donnelly; Anas Saleh; Aasis Unnanuntana; Joseph M Lane
Journal: Curr Opin Support Palliat Care Date: 2012-09 Impact factor: 2.302

2. Atypical proximal femoral fractures in patients with paget disease receiving bisphosphonate therapy.

Authors: Aoife Kilcoyne; Eric J Heffernan
Journal: AJR Am J Roentgenol Date: 2011-07 Impact factor: 3.959

3. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Authors: Dennis M Black; Pierre D Delmas; Richard Eastell; Ian R Reid; Steven Boonen; Jane A Cauley; Felicia Cosman; Péter Lakatos; Ping Chung Leung; Zulema Man; Carlos Mautalen; Peter Mesenbrink; Huilin Hu; John Caminis; Karen Tong; Theresa Rosario-Jansen; Joel Krasnow; Trisha F Hue; Deborah Sellmeyer; Erik Fink Eriksen; Steven R Cummings
Journal: N Engl J Med Date: 2007-05-03 Impact factor: 91.245

Review 4. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors: Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal: J Bone Miner Res Date: 2013-10-01 Impact factor: 6.741

Review 10. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.

Authors: R Rizzoli; K Akesson; M Bouxsein; J A Kanis; N Napoli; S Papapoulos; J-Y Reginster; C Cooper
Journal: Osteoporos Int Date: 2010-11-18 Impact factor: 4.507

Subtrochanteric femoral stress fracture with features of atypical femoral fracture in patient with Paget's disease: a case report.

Review 1. Atypical femoral fractures: epidemiology, etiology, and patient management.

2. Atypical proximal femoral fractures in patients with paget disease receiving bisphosphonate therapy.

3. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

Review 4. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

5. Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy.

6. Bisphosphonate use and subsequent hip fracture in South Korea.

Review 7. Clinician approach to diagnosis of stress fractures including bisphosphonate-associated fractures.

8. Incidence and bone biopsy findings of atypical femoral fractures.

Review 9. Paget disease of bone: therapeutic options.

Review 10. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report.